Nanomedicine at the Pulmonary Frontier: Immune-Centric Approaches for Respiratory Disease Treatment

References

• Abdelaziz, H. M., Gaber, M., Abd-Elwakil, M. M., Mabrouk, M. T., Elgohary, M. M., Kamel, N. M., Kabary, D. M., Freag, M. S., Samaha, M. W., Mortada, S. M., Elkhodairy, K. A., Fang, J. Y., & Elzoghby, A. O. (2018). Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates. Journal of Controlled Release: Official Journal of the Controlled Release Society, 269, 374–392. https://doi.org/10.1016/j.jconrel.2017.11.036
   PubMed Web of Science ®Google Scholar
• Abdella, R., Talyzina, A., Chen, S., Inouye, C. J., Tjian, R., & He, Y. (2021). Structure of the human mediator-bound transcription preinitiation complex. Science, 80. https://doi.org/10.1126/science.abg3074
   Web of Science ®Google Scholar
• Adair, B. M. (2009). Nanoparticle vaccines against respiratory viruses. Wiley Interdisciplinary Reviews Nanomedicine Nanobiotechnology, 1(4), 405–414. https://doi.org/10.1002/wnan.45
   PubMed Web of Science ®Google Scholar
• Adler, K. B., Fischer, B. M., Wright, D. T., Cohn, L. A., & Becker, S. (1994). Interactions between respiratory epithelial cells and cytokines: Relationships to lung inflammation. Annals of the New York Academy of Sciences, 725(1), 128–145. https://doi.org/10.1111/j.1749-6632.1994.tb00275.x
   PubMedGoogle Scholar
• Al-Halifa, S., Gauthier, L., Arpin, D., Bourgault, S., & Archambault, D. (2019). Nanoparticle-based vaccines against respiratory viruses. Frontiers in Immunology, 10. https://doi.org/10.3389/fimmu.2019.00022
   PubMed Web of Science ®Google Scholar
• Alessandrini, F., Vennemann, A., Gschwendtner, S., Neumann, A. U., Rothballer, M., Seher, T., Wimmer, M., Kublik, S., Traidl-Hoffmann, C., Schloter, M., Wiemann, M., & Schmidt-Weber, C. B. (2017). Pro-inflammatory versus immunomodulatory effects of silver nanoparticles in the lung: The critical role of dose, size and surface modification. Nanomaterials, 7(10), 300. https://doi.org/10.3390/nano7100300
   Web of Science ®Google Scholar
• AlMatar, M., Makky, E. A., Yakıcı, G., Var, I., Kayar, B., & Köksal, F. (2018). Antimicrobial peptides as an alternative to anti-tuberculosis drugs. Pharmacological Research, 128, 288–305. https://doi.org/10.1016/j.phrs.2017.10.011
   PubMed Web of Science ®Google Scholar
• Alyahyawi, A. R., Khan, S., Rafi, Z., Singh, P., Moheet, K., Akasha, R., & Ahmad, S. (2023). Exploring kinnow mandarin’s hidden potential: Nature’s key to antimicrobial and antidiabetic gold nanoparticles (K-AuNPs). Saudi Journal of Biological Sciences. https://doi.org/10.1016/j.sjbs.2023.103782
   PubMedGoogle Scholar
• Andersson-Willman, B., Gehrmann, U., Cansu, Z., Buerki-Thurnherr, T., Krug, H. F., Gabrielsson, S., & Scheynius, A. (2012). Effects of subtoxic concentrations of TiO2 and ZnO nanoparticles on human lymphocytes, dendritic cells and exosome production. Toxicology & Applied Pharmacology, 264(1), 94–103. https://doi.org/10.1016/j.taap.2012.07.021
   PubMed Web of Science ®Google Scholar
• Arbiser, Z. K., Guidot, D. M., Pine, J. R., Giltman, L. I., & Gal, A. A. (2003). Pulmonary alveolar proteinosis mimicking idiopathic pulmonary fibrosis. Annals of Diagnostic Pathology, 7(2), 82–86. https://doi.org/10.1016/S1092-9134(02)91214-1
   PubMedGoogle Scholar
• Ariki, S., Nishitani, C., & Kuroki, Y. (2012). Diverse functions of pulmonary collectins in host defense of the lung. Journal of Biomedicine & Biotechnology, 2012, 1–7. https://doi.org/10.1155/2012/532071
   PubMedGoogle Scholar
• Armand, L., Dagouassat, M., Belade, E., Simon-Deckers, A., Le Gouvello, S., Tharabat, C., Duprez, C., Andujar, P., Pairon, J.-C., Boczkowski, J., & Lanone, S. (2013). Titanium dioxide nanoparticles induce matrix metalloprotease 1 in human pulmonary fibroblasts partly via an interleukin-1β–dependent mechanism. American Journal of Respiratory Cell and Molecular Biology, 48(3), 354–363. https://doi.org/10.1165/rcmb.2012-0099OC
   PubMed Web of Science ®Google Scholar
• Arvin, A. M., & Greenberg, H. B. (2006). New viral vaccines. Virology, 344(1), 240–249. https://doi.org/10.1016/j.virol.2005.09.057
   PubMed Web of Science ®Google Scholar
• Baddini Martinez, J. A., King, T. E., Khan, L., Mortenson, R. L., Borish, T. Z., Bost, T. W., & Riches, D. W. H. (1997). Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease. The American Journal of Physiology, 273(3), L676–L683. https://doi.org/10.1152/ajplung.1997.273.3.L676
   PubMedGoogle Scholar
• Baeke, F., Takiishi, T., Korf, H., Gysemans, C., & Mathieu, C. (2010). Vitamin D: Modulator of the immune system. Current Opinion in Pharmacology, 10(4), 482–496. https://doi.org/10.1016/j.coph.2010.04.001
   PubMed Web of Science ®Google Scholar
• Bakshi, M. S., Zhao, L., Smith, R., Possmayer, F., & Petersen, N. O. (2008). Metal nanoparticle pollutants interfere with pulmonary surfactant function in vitro. Biophysical Journal, 94(3), 855–868. https://doi.org/10.1529/biophysj.107.106971
   PubMed Web of Science ®Google Scholar
• Ballester, M., Nembrini, C., Dhar, N., de Titta, A., de Piano, C., Pasquier, M., Simeoni, E., van der Vlies, A. J., McKinney, J. D., Hubbell, J. A., & Swartz, M. A. (2011). Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. Vaccine: X, 29(40), 6959–6966. https://doi.org/10.1016/j.vaccine.2011.07.039
   Google Scholar
• Banchereau, J., & Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature, 392(6673), 245–252. https://doi.org/10.1038/32588
   PubMed Web of Science ®Google Scholar
• Bassis, C. M., Erb-Downward, J. R., Dickson, R. P., Freeman, C. M., Schmidt, T. M., Young, V. B., Beck, J. M., Curtis, J. L., Huffnagle, G. B., & Ravel, J. (2015). Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio, 6(2). https://doi.org/10.1128/mBio.00037-15
   Web of Science ®Google Scholar
• Beck, J. M., Young, V. B., & Huffnagle, G. B. (2012). The microbiome of the lung. Translational Research: The Journal of Laboratory and Clinical Medicine, 160(4), 258–266. https://doi.org/10.1016/j.trsl.2012.02.005
   PubMed Web of Science ®Google Scholar
• Beck-Broichsitter, M., Merkel, O. M., & Kissel, T. (2012). Controlled pulmonary drug and gene delivery using polymeric nano-carriers. Journal of Controlled Release: Official Journal of the Controlled Release Society, 161(2), 214–224. https://doi.org/10.1016/j.jconrel.2011.12.004
   PubMed Web of Science ®Google Scholar
• Belkaid, Y., & Hand, T. W. (2014). Role of the microbiota in immunity and inflammation. Cell, 157(1), 121–141. https://doi.org/10.1016/j.cell.2014.03.011
   PubMed Web of Science ®Google Scholar
• Bezemer, G. F. G., Bauer, S. M., Oberdörster, G., Breysse, P. N., Pieters, R. H. H., Georas, S. N., & Williams, M. A. (2011). Activation of pulmonary dendritic cells and Th2-type inflammatory responses on instillation of engineered, environmental diesel emission source or ambient air pollutant particles in vivo. Journal of Innate Immunity, 3(2), 150–166. https://doi.org/10.1159/000321725
   PubMed Web of Science ®Google Scholar
• Bhattacharya, J., & Matthay, M. A. (2013). Regulation and repair of the alveolar-capillary barrier in acute lung injury. Annual Review of Physiology, 75(1), 593–615. https://doi.org/10.1146/annurev-physiol-030212-183756
   PubMedGoogle Scholar
• Bivas-Benita, M., Lin, M. Y., Bal, S. M., van Meijgaarden, K. E., Franken, K. L. M. C., Friggen, A. H., Junginger, H. E., Borchard, G., Klein, M. R., & Ottenhoff, T. H. M. (2009). Pulmonary delivery of DNA encoding mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA–PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice. Vaccine: X, 27(30), 4010–4017. https://doi.org/10.1016/j.vaccine.2009.04.033
   Google Scholar
• Blank, F., Fytianos, K., Seydoux, E., Rodriguez-Lorenzo, L., Petri-Fink, A., Garnier, C., & Rothen-Rutishauser, B. (2017). Interaction of biomedical nanoparticles with the pulmonary immune system. Journal of Nanobiotechnology, 15(1). https://doi.org/10.1186/s12951-016-0242-5
   PubMedGoogle Scholar
• Blank, F., Stumbles, P. A., Seydoux, E., Holt, P. G., Fink, A., Rothen-Rutishauser, B., Strickland, D. H., & Von Garnier, C. (2013). Size-dependent uptake of particles by pulmonary antigen-presenting cell populations and trafficking to regional lymph nodes. American Journal of Respiratory Cell and Molecular Biology, 49(1), 67–77. https://doi.org/10.1165/rcmb.2012-0387OC
   PubMed Web of Science ®Google Scholar
• Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2020). Nanoparticle-based medicines: A review of FDA-Approved materials and clinical trials to date *. In Nanomaterials and Neoplasms. https://doi.org/10.1201/9780429027819-7
   Google Scholar
• Bogefors, J., Rydberg, C., Uddman, R., Fransson, M., Månsson, A., Benson, M., Adner, M., & Cardell, L. O. (2010). Nod1, Nod2 and Nalp3 receptors, new potential targets in treatment of allergic rhinitis? Allergy European Journal of Allergy and Clinical Immunology is Allergy, 65(10), 1222–1226. https://doi.org/10.1111/j.1398-9995.2009.02315.x
   Google Scholar
• Bonner, J. C. (2010). Nanoparticles as a potential cause of pleural and interstitial lung disease. In Proceedings of the American Thoracic Society, 7, 138–141. https://doi.org/10.1513/pats.200907-061RM
   Google Scholar
• Brown, G. D., & Gordon, S. (2001). A new receptor for β-glucans. Nature, 413(6851), 36–37. https://doi.org/10.1038/35092620
   PubMed Web of Science ®Google Scholar
• Burnham, E. L., Janssen, W. J., Riches, D. W. H., Moss, M., & Downey, G. P. (2014). The fibroproliferative response in acute respiratory distress syndrome: Mechanisms and clinical significance. The European Respiratory Journal, 43(1), 276–285. https://doi.org/10.1183/09031936.00196412
   PubMed Web of Science ®Google Scholar
• Byrne, A. J., Mathie, S. A., Gregory, L. G., & Lloyd, C. M. (2015). Pulmonary macrophages: Key players in the innate defence of the airways. Thorax, 70(12), 1189–1196. https://doi.org/10.1136/thoraxjnl-2015-207020
   PubMed Web of Science ®Google Scholar
• Byron, P. R. (1986). Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation. Journal of Pharmaceutical Sciences, 75(5), 433–438. https://doi.org/10.1002/jps.2600750502
   PubMed Web of Science ®Google Scholar
• Cadena, A. M., Flynn, J. L., & Fortune, S. M. (2016). The importance of first impressions: Early events in mycobacterium tuberculosis infection influence outcome. MBio, 7(2). https://doi.org/10.1128/mBio.00342-16
   PubMed Web of Science ®Google Scholar
• Cai, R., Wang, M., Liu, M., Zhu, X., Feng, L., Yu, Z., Yang, X., Zhang, Z., Guo, H., Guo, R., & Zheng, Y. (2022). An iRGD-conjugated photothermal therapy-responsive gold nanoparticle system carrying siCDK7 induces necroptosis and immunotherapeutic responses in lung adenocarcinoma. Bioengineering & Translational Medicine, 8(4), e10430. n/a. https://doi.org/10.1002/btm2.10430
   PubMed Web of Science ®Google Scholar
• Carney, S. M., Clemente, J. C., Cox, M. J., Dickson, R. P., Huang, Y. J., Kitsios, G. D., Kloepfer, K. M., Leung, J. M., LeVan, T. D., Molyneaux, P. L., Moore, B. B., O’Dwyer, D. N., Segal, L. N., & Garantziotis, S. (2020). Methods in lung microbiome research. American Journal of Respiratory Cell and Molecular Biology, 62(3), 283–299. https://doi.org/10.1165/rcmb.2019-0273TR
   PubMed Web of Science ®Google Scholar
• Carpentier, A., Metellus, P., Ursu, R., Zohar, S., Lafitte, F., Barrié, M., Meng, Y., Richard, M., Parizot, C., Laigle-Donadey, F., Gorochov, G., Psimaras, D., Sanson, M., Tibi, A., Chinot, O., & Carpentier, A. F. (2010). Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: A phase II study. Neuro-Oncology, 12(4), 401–408. https://doi.org/10.1093/neuonc/nop047
   PubMed Web of Science ®Google Scholar
• Chae, J., Choi, Y., Tanaka, M., & Choi, J. (2021). Inhalable nanoparticles delivery targeting alveolar macrophages for the treatment of pulmonary tuberculosis. Journal of Bioscience and Bioengineering, 132(6), 543–551. https://doi.org/10.1016/j.jbiosc.2021.08.009
   PubMed Web of Science ®Google Scholar
• Chellappan, D. K., Sze Ning, Q. L., Su Min, S. K., Bin, S. Y., Chern, P. J., Shi, T. P., Ee Mei, S. W., Yee, T. H., Qi, O. J., Thangavelu, L., Rajeshkumar, S., Negi, P., Chellian, J., Wadhwa, R., Gupta, G., Collet, T., Hansbro, P. M., & Dua, K. (2019). Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases. Chemico-Biological Interactions, 310, 108732. https://doi.org/10.1016/j.cbi.2019.108732
   PubMed Web of Science ®Google Scholar
• Chheang, C., Guinand, S., von Garnier, C., & Sartori, C. (2022). New perspectives of biological therapy for severe asthma in adults and adolescents. Swiss Medical Weekly, 152(2122), w30176. https://doi.org/10.4414/smw.2022.w30176
   PubMedGoogle Scholar
• Chittasupho, C., Xie, S. X., Baoum, A., Yakovleva, T., Siahaan, T. J., & Berkland, C. J. (2009). ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. European Journal of Pharmaceutical Sciences, 37(2), 141–150. https://doi.org/10.1016/j.ejps.2009.02.008
   PubMed Web of Science ®Google Scholar
• Choi, H. S., Ashitate, Y., Lee, J. H., Kim, S. H., Matsui, A., Insin, N., Bawendi, M. G., Semmler-Behnke, M., Frangioni, J. V., & Tsuda, A. (2010). Rapid translocation of nanoparticles from the lung airspaces to the body. Nature Biotechnology, 28(12), 1300–1303. https://doi.org/10.1038/nbt.1696
   PubMed Web of Science ®Google Scholar
• Chotirmall, S. H., Bogaert, D., Chalmers, J. D., Cox, M. J., Hansbro, P. M., Huang, Y. J., Molyneaux, P. L., O’Dwyer, D. N., Pragman, A. A., Rogers, G. B., Segal, L. N., & Dickson, R. P. (2022). Therapeutic targeting of the respiratory microbiome. American Journal of Respiratory and Critical Care Medicine, 206(5), 535–544. https://doi.org/10.1164/rccm.202112-2704PP
   PubMed Web of Science ®Google Scholar
• Christensen, C. L., Kwiatkowski, N., Abraham, B. J., Carretero, J., Al-Shahrour, F., Zhang, T., Chipumuro, E., Herter-Sprie, G. S., Akbay, E. A., Altabef, A., Zhang, J., Shimamura, T., Capelletti, M., Reibel, J. B., Cavanaugh, J. D., Gao, P., Liu, Y., Michaelsen, S. R., Poulsen, H. S., … Wong, K. K. (2014). Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell, 26(6), 909–922. https://doi.org/10.1016/j.ccell.2014.10.019
   PubMed Web of Science ®Google Scholar
• Clark, J. G., Mandac-Dy, J. B., Dixon, A. E., Madtes, D. K., Burkhart, K. M., Harlan, J. M., & Bullard, D. C. (2004). Trafficking of Th1 cells to lung: A role for selectins and a P-Selectin glycoprotein-1-independent ligand. American Journal of Respiratory Cell and Molecular Biology, 30(2), 220–227. https://doi.org/10.1165/rcmb.2003-0208OC
   PubMed Web of Science ®Google Scholar
• Courrier, H. M., Butz, N., & Vandamme, T. F. (2002). Pulmonary drug delivery systems: Recent developments and prospects. Critical Reviews in Therapeutic Drug Carrier Systems, 19(4–5), 425–498. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v19.i45.40
   PubMed Web of Science ®Google Scholar
• Crowe, J. E. (2011). CHAPTER 38 - prevention of fetal and early life infections through maternal–neonatal immunization. In J. S. Remington, J. O. Klein, C. B. Wilson, V. Nizet, & Y. A. Maldonado (Eds.), Infectious diseases of the fetus and newborn (7th ed., pp. 1212–1230). W.B. Saunders. https://doi.org/10.1016/B978-1-4160-6400-8.00038-9
   Google Scholar
• Currie, S. M., Gwyer Findlay, E., McFarlane, A. J., Fitch, P. M., Böttcher, B., Colegrave, N., Paras, A., Jozwik, A., Chiu, C., Schwarze, J., & Davidson, D. J. (2016). Cathelicidins have direct antiviral activity against respiratory syncytial virus in vitro and protective function in vivo in mice and humans. Journal of Immunology, 196(6), 2699–2710. https://doi.org/10.4049/jimmunol.1502478
   PubMed Web of Science ®Google Scholar
• da Silva, M. C., Breckwoldt, M. O., Vinchi, F., Correia, M. P., Stojanovic, A., Thielmann, C. M., Meister, M., Muley, T., Warth, A., Platten, M., Hentze, M. W., Cerwenka, A., & Muckenthaler, M. U. (2017). Iron induces anti-tumor activity in tumor-associated macrophages. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2017.01479
   Google Scholar
• Dankers, A. C. A., Kuper, C. F., Boumeester, A. J., Fabriek, B. O., Kooter, I. M., Gröllers-Mulderij, M., Tromp, P., Nelissen, I., Zondervan Van Den Beuken, E. K., & Vandebriel, R. J. (2018). A practical approach to assess inhalation toxicity of metal oxide nanoparticles in vitro. Journal of Applied Toxicology: JAT, 38(2), 160–171. https://doi.org/10.1002/jat.3518
   PubMed Web of Science ®Google Scholar
• Davidson, D. J., Currie, A. J., Reid, G. S. D., Bowdish, D. M. E., MacDonald, K. L., Ma, R. C., Hancock, R. E. W., & Speert, D. P. (2004). The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. Journal of Immunology, 172(2), 1146–1156. https://doi.org/10.4049/jimmunol.172.2.1146
   PubMed Web of Science ®Google Scholar
• de Martino, M., Lodi, L., Galli, L., & Chiappini, E. (2019). Immune response to mycobacterium tuberculosis: A narrative review. Frontiers in Pediatrics, 7. https://doi.org/10.3389/fped.2019.00350
   Web of Science ®Google Scholar
• De Paula Rogerio, A., Freire Oliveira, C. J., Lemos De Andrade, E., & Haworth, O. (2013). Modulation of lung immune response. BioMed Research International, 2013, 1–3. https://doi.org/10.1155/2013/239020
   Web of Science ®Google Scholar
• de Souza Carvalho, C., Daum, N., & Lehr, C. M. (2014). Carrier interactions with the biological barriers of the lung: Advanced in vitro models and challenges for pulmonary drug delivery. Advanced Drug Delivery Reviews, 75, 129–140. https://doi.org/10.1016/j.addr.2014.05.014
   PubMed Web of Science ®Google Scholar
• De Yang, B., Chen, Q., Schmidt, A. P., Anderson, G. M., Wang, J. M., Wooters, J., Oppenheim, J. J., & Chertov, O. (2000). Ll-37, the neutrophil granule–and epithelial cell–derived cathelicidin, utilizes formyl peptide receptor–like 1 (Fprl1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. Journal of Experimental Medicine, 192(7), 1069–1074. https://doi.org/10.1084/jem.192.7.1069
   PubMed Web of Science ®Google Scholar
• Demedts, I. K., Bracke, K. R., Maes, T., Joos, G. F., & Brusselle, G. G. (2006). Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms. American Journal of Respiratory Cell and Molecular Biology, 35(3), 387–393. https://doi.org/10.1165/rcmb.2005-0382OC
   PubMed Web of Science ®Google Scholar
• DeNardo, D. G., & Ruffell, B. (2019). Macrophages as regulators of tumour immunity and immunotherapy. Nature Reviews Immunology, 19(6), 369–382. https://doi.org/10.1038/s41577-019-0127-6
   PubMed Web of Science ®Google Scholar
• Diamond, G., Beckloff, N., Weinberg, A., & Kisich, K. O. (2009). The roles of antimicrobial peptides in innate host defense. Current Pharmaceutical Design, 15, 2377–2392. https://doi.org/10.2174/138161209788682325
   PubMed Web of Science ®Google Scholar
• Dickson, R. P., Erb-Downward, J. R., Freeman, C. M., McCloskey, L., Falkowski, N. R., Huffnagle, G. B., & Curtis, J. L. (2017). Bacterial topography of the healthy human lower respiratory tract. MBio, 8(1). https://doi.org/10.1128/mBio.02287-16
   PubMed Web of Science ®Google Scholar
• Dickson, R. P., Erb-Downward, J. R., Martinez, F. J., & Huffnagle, G. B. (2016). The microbiome and the respiratory tract. Annual Review of Physiology, 78(1), 481–504. https://doi.org/10.1146/annurev-physiol-021115-105238
   PubMedGoogle Scholar
• Dickson, R. P., Martinez, F. J., & Huffnagle, G. B. (2014). The role of the microbiome in exacerbations of chronic lung diseases. The Lancet, 384(9944), 691–702. https://doi.org/10.1016/S0140-6736(14)61136-3
   PubMed Web of Science ®Google Scholar
• Divangahi, M., Aaby, P., Khader, S. A., Barreiro, L. B., Bekkering, S., Chavakis, T., van Crevel, R., Curtis, N., DiNardo, A. R., Dominguez-Andres, J., Duivenwoorden, R., Fanucchi, S., Fayad, Z., Fuchs, E., Hamon, M., Jeffrey, K. L., Khan, N., Joosten, L. A. B., Kaufmann, E., … Netea, M. G. (2021). Trained immunity, tolerance, priming and differentiation: Distinct immunological processes. Nature Immunology, 22(7), 928–928. https://doi.org/10.1038/s41590-021-00960-y
   PubMed Web of Science ®Google Scholar
• Domagala-Kulawik, J., Osinska, I., & Hoser, G. (2014). Mechanisms of immune response regulation in lung cancer. Translational Lung Cancer Research, 3(1), 15–22. https://doi.org/10.3978/j.issn.2218-6751.2013.11.03
   PubMedGoogle Scholar
• Donaldson, K., Murphy, F. A., Duffin, R., & Poland, C. A. (2010). Asbestos, carbon nanotubes and the pleural mesothelium: A review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Particle and Fibre Toxicology, 7(1), 5. https://doi.org/10.1186/1743-8977-7-5
   PubMed Web of Science ®Google Scholar
• Doroudian, M., O’Neill, A., MacLoughlin, R., Prina-Mello, A., Volkov, Y., & Donnelly, S. C. (2021). Nanotechnology in pulmonary medicine. Current Opinion in Pharmacology, 56, 85–92. https://doi.org/10.1016/j.coph.2020.11.002
   PubMed Web of Science ®Google Scholar
• Dozor, A. J. (2010). The role of oxidative stress in the pathogenesis and treatment of asthma. Annals of the New York Academy of Sciences, 1203(1), 133–137. https://doi.org/10.1111/j.1749-6632.2010.05562.x
   PubMedGoogle Scholar
• Du, L., Zhao, G., Sun, S., Zhang, X., Zhou, X., Guo, Y., Li, Y., Zhou, Y., Jiang, S., & Xu, J. (2013). A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection. PLoS One, 8(1), e53568. https://doi.org/10.1371/journal.pone.0053568
   PubMed Web of Science ®Google Scholar
• Dube, A., Reynolds, J. L., Law, W. C., Maponga, C. C., Prasad, P. N., & Morse, G. D. (2014). Multimodal nanoparticles that provide immunomodulation and intracellular drug delivery for infectious diseases. Nanomedicine: Nanotechnology, Biology and Medicine, 10(4), 831–838. https://doi.org/10.1016/j.nano.2013.11.012
   PubMed Web of Science ®Google Scholar
• Dwivedi, M. V., Harishchandra, R. K., Koshkina, O., Maskos, M., & Galla, H. J. (2014). Size influences the effect of hydrophobic nanoparticles on lung surfactant model systems. Biophysical Journal, 106(1), 289–298. https://doi.org/10.1016/j.bpj.2013.10.036
   PubMed Web of Science ®Google Scholar
• Faner, R., Sibila, O., Agustí, A., Bernasconi, E., Chalmers, J. D., Huffnagle, G. B., Manichanh, C., Molyneaux, P. L., Paredes, R., Brocal, V. P., Ponomarenko, J., Sethi, S., Dorca, J., & Monsó, E. (2017). The microbiome in respiratory medicine: Current challenges and future perspectives. European Respiratory Journal, 49(4), 1602086. https://doi.org/10.1183/13993003.02086-2016
   PubMed Web of Science ®Google Scholar
• Feng, Z. V., Gunsolus, I. L., Qiu, T. A., Hurley, K. R., Nyberg, L. H., Frew, H., Johnson, K. P., Vartanian, A. M., Jacob, L. M., Lohse, S. E., Torelli, M. D., Hamers, R. J., Murphy, C. J., & Haynes, C. L. (2015). Impacts of gold nanoparticle charge and ligand type on surface binding and toxicity to gram-negative and gram-positive bacteria. Chemical Science, 6(9), 5186–5196. https://doi.org/10.1039/c5sc00792e
   PubMed Web of Science ®Google Scholar
• Fisher, R. P., & Morgan, D. O. (1994). A novel cyclin associates with M015/CDK7 to form the CDK-activating kinase. Cell, 78(4), 713–724. https://doi.org/10.1016/0092-8674(94)90535-5
   PubMed Web of Science ®Google Scholar
• Fontana, J. M., Alexander, E., & Salvatore, M. (2012). Translational research in infectious disease: Current paradigms and challenges ahead. Translational Research: The Journal of Laboratory and Clinical Medicine, 159(6), 430–453. https://doi.org/10.1016/j.trsl.2011.12.009
   PubMed Web of Science ®Google Scholar
• Freeburn, R. W., Armstrong, L., & Millar, A. B. (2005). Cultured alveolar macrophages from patients with Idiopathic Pulmonary Fibrosis (IPF) show dysregulation of lipopolysaccharide-induced Tumor Necrosis Factor-α (TNF-α) and interleukin-10 (IL-10) inductions. European Cytokine Network, 16(1), 5–16.
   PubMed Web of Science ®Google Scholar
• Fytianos, K., Drasler, B., Blank, F., Von Garnier, C., Seydoux, E., Rodriguez-Lorenzo, L., Petri-Fink, A., & Rothen-Rutishauser, B. (2016). Current in vitro approaches to assess nanoparticle interactions with lung cells. Nanomedicine: Nanotechnology, Biology and Medicine, 11(18), 2457–2469. https://doi.org/10.2217/nnm-2016-0199
   PubMed Web of Science ®Google Scholar
• Gao, S., Yang, X., Xu, J., Qiu, N., & Zhai, G. (2021). Nanotechnology for boosting cancer immunotherapy and remodeling tumor microenvironment: The horizons in cancer treatment. Agricultural Science & Technology Nano, 15(8), 12567–12603. https://doi.org/10.1021/acsnano.1c02103
   Google Scholar
• Garcia-Contreras, L., Wong, Y. L., Muttil, P., Padilla, D., Sadoff, J., DeRousse, J., Germishuizen, W. A., Goonesekera, S., Elbert, K., Bloom, B. R., Miller, R., Fourie, P. B., Hickey, A., & Edwards, D. (2008). Immunization by a bacterial aerosol. Proceedings of the National Academy of Sciences of the United States of America, 105(12), 4656–4660. https://doi.org/10.1073/pnas.0800043105
   PubMed Web of Science ®Google Scholar
• Gates, K., & Martinez, F. (2016). The human microbiome in the lung: Are infections contributing to lung health and disease? Chronic Obstr. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, 3(1), 466–472. https://doi.org/10.15326/jcopdf.3.1.2015.0174
   PubMedGoogle Scholar
• Gehr, P., Bachofen, M., & Weibel, E. R. (1978). The normal human lung: Ultrastructure and morphometric estimation of diffusion capacity. Respiration Physiology, 32(2), 121–140. https://doi.org/10.1016/0034-5687(78)90104-4
   PubMedGoogle Scholar
• Geiser, M., & Kreyling, W. G. (2010). Deposition and biokinetics of inhaled nanoparticles. Particle and Fibre Toxicology, 7(1), 2. https://doi.org/10.1186/1743-8977-7-2
   PubMed Web of Science ®Google Scholar
• Ghezzi, C., Wong, A., Chen, B. Y., Ribalet, B., Damoiseaux, R., & Clark, P. M. (2019). A high-throughput screen identifies that CDK7 activates glucose consumption in lung cancer cells. Nature Communications, 10(1). https://doi.org/10.1038/s41467-019-13334-8
   PubMedGoogle Scholar
• Gold, M. C., Napier, R. J., & Lewinsohn, D. M. (2015). MR1-restricted Mucosal Associated Invariant T (MAIT) cells in the immune response to mycobacterium tuberculosis. Immunological Reviews, 264(1), 154–166. https://doi.org/10.1111/imr.12271
   PubMed Web of Science ®Google Scholar
• Gong, W., & Wu, X. (2021). Differential diagnosis of latent tuberculosis infection and active tuberculosis: A key to a successful tuberculosis control strategy. Frontiers in Microbiology, 12, 745592. https://doi.org/10.3389/fmicb.2021.745592
   PubMed Web of Science ®Google Scholar
• González-Sánchez, E., Muñoz-Callejas, A., Gómez-Román, J., San Antonio, E., Marengo, A., Tsapis, N., Bohne-Japiassu, K., González-Tajuelo, R., Pereda, S., García-Pérez, J., Cavagna, L., González-Gay, M. Á., Vicente-Rabaneda, E. F., Meloni, F., Fattal, E., Castañeda, S., & Urzainqui, A. (2022). Targeted nanotherapy with everolimus reduces inflammation and fibrosis in scleroderma-related interstitial lung disease developed by PSGL-1 deficient mice. British Journal of Pharmacology, 179(18), 4534–4548. https://doi.org/10.1111/bph.15898
   PubMed Web of Science ®Google Scholar
• Greco, E., Quintiliani, G., Santucci, M. B., Serafino, A., Ciccaglione, A. R., Marcantonio, C., Papi, M., Maulucci, G., Delogu, G., Martino, A., Goletti, D., Sarmati, L., Andreoni, M., Altieri, A., Alma, M., Caccamo, N., DiLiberto, D., De Spirito, M., Savage, N. D., … Fraziano, M. (2012). Janus-faced liposomes enhance antimicrobial innate immune response in mycobacterium tuberculosis infection. Proceedings of the National Academy of Sciences of the United States of America, 109(21). https://doi.org/10.1073/pnas.1200484109
   PubMed Web of Science ®Google Scholar
• Greenlee, K. J., Werb, Z., & Kheradmand, F. (2007). Matrix metalloproteinases in lung: Multiple, multifarious, and multifaceted. Physiological Reviews, 87(1), 69–98. https://doi.org/10.1152/physrev.00022.2006
   PubMed Web of Science ®Google Scholar
• Griesmann, H., Drexel, C., Milosevic, N., Sipos, B., Rosendahl, J., Gress, T. M., & Michl, P. (2017). Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer. Gut, 66(7), 1278–1285. https://doi.org/10.1136/gutjnl-2015-310049
   PubMed Web of Science ®Google Scholar
• Gwyer Findlay, E., Currie, S. M., & Davidson, D. J. (2013). Cationic host defence peptides: Potential as antiviral therapeutics. BioDrugs, 27(5), 479–493. https://doi.org/10.1007/s40259-013-0039-0
   PubMed Web of Science ®Google Scholar
• Halwani, R., Sultana Shaik, A., Ratemi, E., Afzal, S., Kenana, R., Al-Muhsen, S., & Al Faraj, A. (2016). A novel anti-IL4Rα nanoparticle efficiently controls lung inflammation during asthma. Experimental & Molecular Medicine, 48(10), e262–e262. https://doi.org/10.1038/emm.2016.89
   PubMedGoogle Scholar
• Hammad, H., & Lambrecht, B. N. (2015). Barrier epithelial cells and the control of type 2 immunity. Immunity, 43(1), 29–40. https://doi.org/10.1016/j.immuni.2015.07.007
   PubMed Web of Science ®Google Scholar
• Hardy, C. L., LeMasurier, J. S., Belz, G. T., Scalzo-Inguanti, K., Yao, J., Xiang, S. D., Kanellakis, P., Bobik, A., Strickland, D. H., Rolland, J. M., O’Hehir, R. E., & Plebanski, M. (2012). Inert 50-nm polystyrene nanoparticles that modify pulmonary dendritic cell function and inhibit allergic airway inflammation. Journal of Immunology, 188(3), 1431–1441. https://doi.org/10.4049/jimmunol.1100156
   PubMed Web of Science ®Google Scholar
• Hardy, C. L., LeMasurier, J. S., Mohamud, R., Yao, J., Xiang, S. D., Rolland, J. M., O’Hehir, R. E., & Plebanski, M. (2013). Differential uptake of nanoparticles and microparticles by pulmonary APC subsets induces discrete immunological imprints. Journal of Immunology, 191(10), 5278–5290. https://doi.org/10.4049/jimmunol.1203131
   PubMed Web of Science ®Google Scholar
• Harjunpää, H., Asens, M. L., Guenther, C., & Fagerholm, S. C. (2019). Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2019.01078
   Web of Science ®Google Scholar
• Hartl, D., Tirouvanziam, R., Laval, J., Greene, C. M., Habiel, D., Sharma, L., Yildirim, A. Ö., Dela Cruz, C. S., & Hogaboam, C. M. (2018). Innate immunity of the lung: From basic mechanisms to translational medicine. Journal of Innate Immunity, 10(5–6), 487–501. https://doi.org/10.1159/000487057
   PubMed Web of Science ®Google Scholar
• Heyder, J., Gebhart, J., Rudolf, G., Schiller, C. F., & Stahlhofen, W. (1986). Deposition of particles in the human respiratory tract in the size range 0.005–15 μm. Journal of Aerosol Science, 17(5), 811–825. https://doi.org/10.1016/0021-8502(86)90035-2
   Web of Science ®Google Scholar
• Hidalgo, A., Cruz, A., & Pérez-Gil, J. (2015). Barrier or carrier? Pulmonary surfactant and drug delivery. European Journal of Pharmaceutics & Biopharmaceutics, 95, 117–127. https://doi.org/10.1016/j.ejpb.2015.02.014
   PubMed Web of Science ®Google Scholar
• Hidalgo, A., Cruz, A., & Pérez-Gil, J. (2017). Pulmonary surfactant and nanocarriers: Toxicity versus combined nanomedical applications. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1859(9), 1740–1748. https://doi.org/10.1016/j.bbamem.2017.04.019
   PubMed Web of Science ®Google Scholar
• Hinks, T. S. C., Wallington, J. C., Williams, A. P., Djukanovic, R., Staples, K. J., & Wilkinson, T. M. A. (2016). Steroid-induced deficiency of mucosal-associated invariant T cells in the chronic obstructive pulmonary disease lung. Implications for nontypeable Haemophilus influenzae infection. American Journal of Respiratory and Critical Care Medicine, 194(10), 1208–1218. https://doi.org/10.1164/rccm.201601-0002OC
   PubMed Web of Science ®Google Scholar
• Hsu, R.-J., Yu, W.-C., Peng, G.-R., Ye, C.-H., Hu, S., Chong, P. C. T., Yap, K. Y., Lee, J. Y. C., Lin, W.-C., & Yu, S.-H. (2022). The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections. Frontiers in Immunology, 13, 832394. https://doi.org/10.3389/fimmu.2022.832394
   PubMed Web of Science ®Google Scholar
• Huang, Y. J., Charlson, E. S., Collman, R. G., Colombini-Hatch, S., Martinez, F. D., & Senior, R. M. (2013). The role of the lung microbiome in health and disease. American Journal of Respiratory and Critical Care Medicine, 187(12), 1382–1387. https://doi.org/10.1164/rccm.201303-0488WS
   PubMed Web of Science ®Google Scholar
• Huang, Y. J., Nelson, C. E., Brodie, E. L., Desantis, T. Z., Baek, M. S., Liu, J., Woyke, T., Allgaier, M., Bristow, J., Wiener-Kronish, J. P., Sutherland, E. R., King, T. S., Icitovic, N., Martin, R. J., Calhoun, W. J., Castro, M., Denlinger, L. C., Dimango, E., Kraft, M., … Lynch, S. V. (2011). Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. The Journal of Allergy and Clinical Immunology, 127(2), 372–381.e3. https://doi.org/10.1016/j.jaci.2010.10.048
   PubMed Web of Science ®Google Scholar
• Huang, Y. J., Sethi, S., Murphy, T., Nariya, S., Boushey, H. A., Lynch, S. V., & Gilligan, P. H. (2014). Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. Journal of Clinical Microbiology, 52(8), 2813–2823. https://doi.org/10.1128/JCM.00035-14
   PubMed Web of Science ®Google Scholar
• Hussain, S., Boland, S., Baeza-Squiban, A., Hamel, R., Thomassen, L. C. J., Martens, J. A., Billon-Galland, M. A., Fleury-Feith, J., Moisan, F., Pairon, J. C., & Marano, F. (2009). Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: Role of particle surface area and internalized amount. Toxicology, 260(1–3), 142–149. https://doi.org/10.1016/j.tox.2009.04.001
   PubMed Web of Science ®Google Scholar
• Hussain, S., Vanoirbeek, J. A. J., Luyts, K., De Vooght, V., Verbeken, E., Thomassen, L. C. J., Martens, J. A., Dinsdale, D., Boland, S., Marano, F., Nemery, B., & Hoet, P. H. M. (2011). Lung exposure to nanoparticles modulates an asthmatic response in a mouse model. The European Respiratory Journal, 37(2), 299–309. https://doi.org/10.1183/09031936.00168509
   PubMed Web of Science ®Google Scholar
• Hwang, I., Kim, J. W., Ylaya, K., Chung, E. J., Kitano, H., Perry, C., Hanaoka, J., Fukuoka, J., Chung, J. Y., & Hewitt, S. M. (2020). Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients. Journal of Translational Medicine, 18(1). https://doi.org/10.1186/s12967-020-02618-z
   Web of Science ®Google Scholar
• Hwang, J., Son, J., Seo, Y., Jo, Y., Lee, K., Lee, D., Khan, M. S., Chavan, S., Park, C., Sharma, A., Gilad, A. A., & Choi, J. (2018). Functional silica nanoparticles conjugated with beta-glucan to deliver anti-tuberculosis drug molecules. Journal of Industrial & Engineering Chemistry, 58, 376–385. https://doi.org/10.1016/j.jiec.2017.09.051
   Web of Science ®Google Scholar
• Inoue, K. I., Takano, H., Koike, E., Yanagisawa, R., Sakurai, M., Tasaka, S., Ishizaka, A., & Shimada, A. (2008). Effects of pulmonary exposure to carbon nanotubes on lung and systemic inflammation with coagulatory disturbance induced by lipopolysaccharide in mice. Experimental Biology and Medicine, 233(12), 1583–1590. https://doi.org/10.3181/0805-RM-179
   PubMed Web of Science ®Google Scholar
• Inoue, K. I., Takano, H., Yanagisawa, R., Sakurai, M., Ichinose, T., Sadakane, K., & Yoshikawa, T. (2005). Effects of nano particles on antigen-related airway inflammation in mice. Respiratory Research, 6(1). https://doi.org/10.1186/1465-9921-6-106
   PubMedGoogle Scholar
• Isahak, N., Sanchez, J., Perrier, S., Stone, M. J., & Payne, R. J. (2016). Synthesis of polymers and nanoparticles bearing polystyrene sulfonate brushes for chemokine binding. Organic & Biomolecular Chemistry, 14(24), 5652–5658. https://doi.org/10.1039/c6ob00270f
   PubMed Web of Science ®Google Scholar
• Iwasaki, A., Foxman, E. F., & Molony, R. D. (2017). Early local immune defences in the respiratory tract. Nature Reviews Immunology, 17(1), 7–20. https://doi.org/10.1038/nri.2016.117
   PubMed Web of Science ®Google Scholar
• Jahnsen, F. L., Strickland, D. H., Thomas, J. A., Tobagus, I. T., Napoli, S., Zosky, G. R., Turner, D. J., Sly, P. D., Stumbles, P. A., & Holt, P. G. (2006). Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus. Journal of Immunology, 177(9), 5861–5867. https://doi.org/10.4049/jimmunol.177.9.5861
   PubMed Web of Science ®Google Scholar
• Janssen, W. J., Stefanski, A. L., Bochner, B. S., & Evans, C. M. (2016). Control of lung defence by mucins and macrophages: Ancient defence mechanisms with modern functions. The European Respiratory Journal, 48(4), 1201–1214. https://doi.org/10.1183/13993003.00120-2015
   PubMed Web of Science ®Google Scholar
• Jasim, F. A., Suker, D. K., & AL- Badran, A. I. (2017). TiO2 nanoparticles induce lung fibrosis and proteinosis through influence on matrix metalloproteinase expression. International Journal of Sciences, 3(3), 1–13. https://doi.org/10.18483/ijsci.1197
   Google Scholar
• Jeong, M. J., Jeon, S., Yu, H. S., Cho, W. S., Lee, S., Kang, D., Kim, Y., Kim, Y. J., & Kim, S. Y. (2022). Exposure to nickel oxide nanoparticles induces acute and chronic inflammatory responses in rat lungs and perturbs the lung microbiome. International Journal of Environmental Research and Public Health, 19(1), 522. https://doi.org/10.3390/ijerph19010522
   PubMed Web of Science ®Google Scholar
• Johannson, K. A., Balmes, J. R., & Collard, H. R. (2015). Air pollution exposure: A novel environmental risk factor for interstitial lung disease? Chest, 147(4), 1161–1167. https://doi.org/10.1378/chest.14-1299
   PubMed Web of Science ®Google Scholar
• Joo, S. H., & Aggarwal, S. (2018). Factors impacting the interactions of engineered nanoparticles with bacterial cells and biofilms: Mechanistic insights and state of knowledge. Journal of Environmental Management, 225, 62–74. https://doi.org/10.1016/j.jenvman.2018.07.084
   PubMed Web of Science ®Google Scholar
• Kanojia, G., Have, R. T., Soema, P. C., Frijlink, H., Amorij, J. P., & Kersten, G. (2017). Developments in the formulation and delivery of spray dried vaccines. Human Vaccines & Immunotherapeutics, 13(10), 2364–2378. https://doi.org/10.1080/21645515.2017.1356952
   PubMed Web of Science ®Google Scholar
• Kasper, J. Y., Feiden, L., Hermanns, M. I., Bantz, C., Maskos, M., Unger, R. E., & Kirkpatrick, C. J. (2015). Pulmonary surfactant augments cytotoxicity of silica nanoparticles: Studies on an in vitro air–blood barrier model. Beilstein Journal of Nanotechnology, 6, 517–528. https://doi.org/10.3762/bjnano.6.54
   PubMed Web of Science ®Google Scholar
• Keating, E., Zuo, Y. Y., Tadayyon, S. M., Petersen, N. O., Possmayer, F., & Veldhuizen, R. A. W. (2012). A modified squeeze-out mechanism for generating high surface pressures with pulmonary surfactant. Biochimica et Biophysica Acta - Biomembranes, 1818(5), 1225–1234. https://doi.org/10.1016/j.bbamem.2011.12.007
   Web of Science ®Google Scholar
• Khademi, F., Derakhshan, M., Yousefi-Avarvand, A., & Tafaghodi, M. (2018). Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review. Iranian Journal of Basic Medical Sciences, 21(2), 116–123. https://doi.org/10.22038/ijbms.2017.22059.5648
   PubMed Web of Science ®Google Scholar
• Khan, N., Vidyarthi, A., Javed, S., & Agrewala, J. N. (2016). Innate immunity holding the flanks until reinforced by adaptive immunity against mycobacterium tuberculosis infection. Frontiers in Microbiology, 7. https://doi.org/10.3389/fmicb.2016.00328
   Google Scholar
• Kim, S. H., & Jang, Y. S. (2017). The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants. Clinical and Experimental Vaccine Research, 6(1), 15. https://doi.org/10.7774/cevr.2017.6.1.15
   PubMed Web of Science ®Google Scholar
• Kong, X., Hellermann, G. R., Zhang, W., Jena, P., Kumar, M., Behera, A., Behera, S., Lockey, R., & Mohapatra, S. S. (2008). Chitosan interferon-γ nanogene therapy for lung disease: Modulation of T-cell and dendritic cell immune responses. Allergy, Asthma, and Clinical Immunology, 4(3). https://doi.org/10.1186/1710-1492-4-3-95
   PubMedGoogle Scholar
• Korbel, D. S., Schneider, B. E., & Schaible, U. E. (2008). Innate immunity in tuberculosis: Myths and truth. Microbes & Infection, 10(9), 995–1004. https://doi.org/10.1016/j.micinf.2008.07.039
   PubMed Web of Science ®Google Scholar
• Kreyling, W. G., Semmler-Behnke, M., Takenaka, S., & Möller, W. (2013). Differences in the biokinetics of inhaled nano-versus micrometer-sized particles. Accounts of Chemical Research, 46(3), 714–722. https://doi.org/10.1021/ar300043r
   PubMed Web of Science ®Google Scholar
• Krieg, A. M. (2007). Development of TLR9 agonists for cancer therapy. Journal of Clinical Investigation, 117(5), 1184–1194. https://doi.org/10.1172/JCI31414
   PubMed Web of Science ®Google Scholar
• Kwon, Y. S., Jin, H. M., Cho, Y. N., Kim, M. J., Kang, J. H., Jung, H. J., Park, K. J., Kee, H. J., Kee, S. J., & Park, Y. W. (2016). Mucosal-associated invariant T cell deficiency in chronic obstructive pulmonary disease. COPD: Journal of Chronic Obstructive Pulmonary Disease, 13(2), 196–202. https://doi.org/10.3109/15412555.2015.1069806
   PubMed Web of Science ®Google Scholar
• Lal, C. V., Travers, C., Aghai, Z. H., Eipers, P., Jilling, T., Halloran, B., Carlo, W. A., Keeley, J., Rezonzew, G., Kumar, R., Morrow, C., Bhandari, V., & Ambalavanan, N. (2016). The airway microbiome at birth. Scientific Reports, 6(1). https://doi.org/10.1038/srep31023
   Google Scholar
• Le, Q. V., Yang, G., Wu, Y., Jang, H. W., Shokouhimehr, M., & Oh, Y. K. (2019). Nanomaterials for modulating innate immune cells in cancer immunotherapy. Asian Journal of Pharmaceutical Sciences, 14(1), 16–29. https://doi.org/10.1016/j.ajps.2018.07.003
   PubMed Web of Science ®Google Scholar
• Lee, J. K., Sayers, B. C., Chun, K. S., Lao, H. C., Shipley-Phillips, J. K., Bonner, J. C., & Langenbach, R. (2012). Multi-walled carbon nanotubes induce COX-2 and iNOS expression via MAP kinase-dependent and -independent mechanisms in mouse RAW264.7 macrophages. Particle and Fibre Toxicology, 9(1). https://doi.org/10.1186/1743-8977-9-14
   PubMedGoogle Scholar
• Lee, Y. T., Ko, E. J., Kim, K. H., Hwang, H. S., Lee, Y., Kwon, Y. M., Kim, M. C., Lee, Y. N., Jung, Y. J., & Kang, S. M. (2017). Cellular immune correlates preventing disease against respiratory syncytial virus by vaccination with virus-like nanoparticles carrying fusion proteins. Journal of Biomedical Nanotechnology, 13(1), 84–98. https://doi.org/10.1166/jbn.2017.2341
   PubMed Web of Science ®Google Scholar
• Li, K. J., Chen, Z. L., Huang, Y., Zhang, R., Luan, X. Q., Lei, T. T., & Chen, L. (2019). Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety. Respiratory Research, 20(1). https://doi.org/10.1186/s12931-019-1246-0
   Web of Science ®Google Scholar
• Li, Z., Li, Y., Sun, Q., Wei, J., Li, B., Qiu, Y., Liu, K., Shao, D., & Ma, Z. (2022). Targeting the pulmonary microbiota to fight against respiratory diseases. Cells, 11(5), 916. https://doi.org/10.3390/cells11050916
   PubMed Web of Science ®Google Scholar
• Lipscomb, M. F., Hutt, J., Lovchik, J., Wu, T., & Lyons, C. R. (2010). The pathogenesis of acute pulmonary viral and bacterial infections: Investigations in animal models. Annual Review of Pathology: Mechanisms of Disease, 5(1), 223–252. https://doi.org/10.1146/annurev-pathol-121808-102153
   PubMedGoogle Scholar
• Liu, J., Liu, Z., Pang, Y., & Zhou, H. (2022). The interaction between nanoparticles and immune system: Application in the treatment of inflammatory diseases. Journal of Nanobiotechnology, 20(1), 127. https://doi.org/10.1186/s12951-022-01343-7
   PubMed Web of Science ®Google Scholar
• Liu, Y., Tang, X., Tian, J., Zhu, C., Peng, H., Rui, K., Wang, Y., Mao, C., Ma, J., Lu, L., Xu, H., & Wang, S. (2014). Th17/Treg cells imbalance and GITRL profile in patients with Hashimoto’s thyroiditis. International Journal of Molecular Sciences, 15(12), 21674–21686. https://doi.org/10.3390/ijms151221674
   PubMed Web of Science ®Google Scholar
• Locke, B. W., Lee, J. J., & Sundar, K. M. (2022). {OSA} and chronic respiratory disease: Mechanisms and epidemiology. International Journal of Environmental Research and Public Health, 19(9), 5473. https://doi.org/10.3390/ijerph19095473
   PubMed Web of Science ®Google Scholar
• Lopez-Rodriguez, E., Gay-Jordi, G., Mucci, A., Lachmann, N., & Serrano-Mollar, A. (2017). Lung surfactant metabolism: Early in life, early in disease and target in cell therapy. Cell and Tissue Research, 367(3), 721–735. https://doi.org/10.1007/s00441-016-2520-9
   PubMed Web of Science ®Google Scholar
• Lund, F. E., Hollifield, M., Schuer, K., Lines, J. L., Randall, T. D., & Garvy, B. A. (2006). B cells are required for generation of protective effector and memory CD4 cells in response to pneumocystis lung infection. Journal of Immunology, 176(10), 6147–6154. https://doi.org/10.4049/jimmunol.176.10.6147
   PubMed Web of Science ®Google Scholar
• Luo, M. X., Hua, S., & Shang, Q. Y. (2021). Application of nanotechnology in drug delivery systems for respiratory diseases (review). Molecular Medicine Reports, 23(5). https://doi.org/10.3892/mmr.2021.11964
   Web of Science ®Google Scholar
• MacLean, J. A., Xia, W., Pinto, C. E., Zhao, L., Liu, H. W., & Kradin, R. L. (1996). Sequestration of inhaled particulate antigens by lung phagocytes. A mechanism for the effective inhibition of pulmonary cell-mediated immunity. The American Journal of Pathology, 148(2), 657–666.
   PubMed Web of Science ®Google Scholar
• Malhotra, J., Jabbour, S. K., & Aisner, J. (2017). Current state of immunotherapy for non-small cell lung cancer. Translational Lung Cancer Research, 6(5), 612–612. https://doi.org/10.21037/tlcr.2017.08.08
   PubMed Web of Science ®Google Scholar
• Malik, G., & Zhou, Y. (2020). Innate immune sensing of influenza a virus. Viruses, 12(7), 755. https://doi.org/10.3390/v12070755
   PubMed Web of Science ®Google Scholar
• Mallapragada, S. K., & Narasimhan, B. (2008). Immunomodulatory biomaterials. International Journal of Pharmaceutics, 364(2), 265–271. https://doi.org/10.1016/j.ijpharm.2008.06.030
   PubMed Web of Science ®Google Scholar
• Man, W. H., De Steenhuijsen Piters, W. A. A., & Bogaert, D. (2017). The microbiota of the respiratory tract: Gatekeeper to respiratory health. Nature Reviews Microbiology, 15(5), 259–270. https://doi.org/10.1038/nrmicro.2017.14
   PubMed Web of Science ®Google Scholar
• Markiewski, M. M., & Lambris, J. D. (2007). The role of complement in inflammatory diseases from behind the scenes into the spotlight. The American Journal of Pathology. https://doi.org/10.2353/ajpath.2007.070166
   PubMed Web of Science ®Google Scholar
• Mejías, J. C., Forrest, O. A., Margaroli, C., Rubio, D. A. F., Viera, L., Li, J., Xu, X., Gaggar, A., Tirouvanziam, R., & Roy, K. (2019). Neutrophil-targeted, protease-activated pulmonary drug delivery blocks airway and systemic inflammation. JCI Insight, 4(23). https://doi.org/10.1172/jci.insight.131468
   PubMed Web of Science ®Google Scholar
• Meraz, I. M., Majidi, M., Cao, X., Lin, H., Li, L., Wang, J., Baladandayuthapani, V., Rice, D., Sepesi, B., Ji, L., & Roth, J. A. (2018). TUSC2 immunogene therapy synergizes with anti–PD-1 through enhanced proliferation and infiltration of natural killer cells in Syngeneic Kras -mutant mouse lung cancer models. Cancer Immunology Research, 6(2), 163–177. https://doi.org/10.1158/2326-6066.CIR-17-0273
   PubMed Web of Science ®Google Scholar
• Moore, T. L., Rodriguez-Lorenzo, L., Hirsch, V., Balog, S., Urban, D., Jud, C., Rothen-Rutishauser, B., Lattuada, M., & Petri-Fink, A. (2015). Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. Chemical Society Reviews, 44(17), 6287–6305. https://doi.org/10.1039/c4cs00487f
   PubMed Web of Science ®Google Scholar
• Moretta, A. (2005). The dialogue between human natural killer cells and dendritic cells. Current Opinion in Immunology, 17(3), 306–311. https://doi.org/10.1016/j.coi.2005.03.004
   PubMed Web of Science ®Google Scholar
• Moriyama, K., Ishizaka, A., Nakamura, M., Kubo, H., Kotani, T., Yamamoto, S., Ogawa, E. N., Kajikawa, O., Frevert, C. W., Kotake, Y., Morisaki, H., Koh, H., Tasaka, S., Martin, T. R., & Takeda, J. (2004). Enhancement of the endotoxin recognition pathway by ventilation with a large tidal volume in rabbits. American Journal of Physiology-Lung Cellular and Molecular Physiology, 286(6), L1114–L1121. https://doi.org/10.1152/ajplung.00296.2003
   PubMed Web of Science ®Google Scholar
• Murphy, F. A., Schinwald, A., Poland, C. A., & Donaldson, K. (2012). The mechanism of pleural inflammation by long carbon nanotubes: Interaction of long fibres with macrophages stimulates them to amplify pro-inflammatory responses in mesothelial cells. Particle and Fibre Toxicology, 9(1). https://doi.org/10.1186/1743-8977-9-8
   PubMedGoogle Scholar
• Nathan, A. T., Peterson, E. A., Chakir, J., & Wills-Karp, M. (2009). Innate immune responses of airway epithelium to house dust mite are mediated through β-glucan–dependent pathways. The Journal of Allergy and Clinical Immunology, 123(3), 612–618. https://doi.org/10.1016/j.jaci.2008.12.006
   PubMed Web of Science ®Google Scholar
• Navarro-Torné, A., Vidal, M., Trzaska, D. K., Passante, L., Crisafulli, A., Laang, H., Van De Loo, J. W., Berkouk, K., & Draghia-Akli, R. (2015). Chronic respiratory diseases and lung cancer research: A perspective from the European union. The European Respiratory Journal, 46(5), 1270–1280. https://doi.org/10.1183/13993003.00395-2015
   PubMed Web of Science ®Google Scholar
• Nelson, B. N., Hawkins, A. N., & Wozniak, K. L. (2020). Pulmonary macrophage and dendritic cell responses to Cryptococcus neoformans. Frontiers in Cellular and Infection Microbiology, 10. https://doi.org/10.3389/fcimb.2020.00037
   Web of Science ®Google Scholar
• Nelson, D. J., McMenamin, C., McWilliam, A. S., Brenan, M., & Holt, P. G. (1994). Development of the airway intraepithelial dendritic cell network in the rat from class II major histocompatibility (ia)-negative precursors: Differential regulation of ia expression at different levels of the respiratory tract. Journal of Experimental Medicine, 179(1), 203–212. https://doi.org/10.1084/jem.179.1.203
   PubMed Web of Science ®Google Scholar
• Nemmar, A., Al-Salam, S., Beegam, S., Yuvaraju, P., & Ali, B. H. (2017). The acute pulmonary and thrombotic effects of cerium oxide nanoparticles after intratracheal instillation in mice. International Journal of Nanomedicine, 12, 2913–2922. https://doi.org/10.2147/IJN.S127180
   PubMed Web of Science ®Google Scholar
• Nemmar, A., Yuvaraju, P., Beegam, S., Yasin, J., Al Dhaheri, R., Fahim, M. A., & Ali, B. H. (2015). In vitro platelet aggregation and oxidative stress caused by amorphous silica nanoparticles. International Journal of Physiology, Pathophysiology and Pharmacology, 7(1), 27–33.
   PubMedGoogle Scholar
• Nicod, L. P. (2005). Lung defences: An overview. European Respiratory Review, 14(95), 45–50. https://doi.org/10.1183/09059180.05.00009501
   Google Scholar
• Nishanth, R. P., Jyotsna, R. G., Schlager, J. J., Hussain, S. M., & Reddanna, P. (2011). Inflammatory responses of RAW 264.7 macrophages upon exposure to nanoparticles: Role of ROS-NFκB signaling pathway. Nanotoxicology, 5(4), 502–516. https://doi.org/10.3109/17435390.2010.541604
   PubMed Web of Science ®Google Scholar
• Nishi, K. I., Kadoya, C., Ogami, A., Oyabu, T., Morimoto, Y., Ueno, S., & Myojo, T. (2020). Changes over time in pulmonary inflammatory response in rat lungs after intratracheal instillation of nickel oxide nanoparticles. Journal of Occupational Health, 62(1). https://doi.org/10.1002/1348-9585.12162
   PubMed Web of Science ®Google Scholar
• O’Dwyer, D. N., Dickson, R. P., & Moore, B. B. (2016). The lung microbiome, immunity, and the pathogenesis of chronic lung disease. Journal of Immunology, 196(12), 4839–4847. https://doi.org/10.4049/jimmunol.1600279
   PubMed Web of Science ®Google Scholar
• Oh, C. K., Geba, G. P., & Molfino, N. (2010). Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma. European Respiratory Review, 19, 46–54. https://doi.org/10.1183/09059180.00007609
   PubMedGoogle Scholar
• Ohaegbulam, K. C., Assal, A., Lazar-Molnar, E., Yao, Y., & Zang, X. (2015). Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends in Molecular Medicine, 21(1), 24–33. https://doi.org/10.1016/j.molmed.2014.10.009
   PubMed Web of Science ®Google Scholar
• Parra, E., & Pérez-Gil, J. (2015). Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films. Chemistry and Physics of Lipids, 185, 153–175. https://doi.org/10.1016/j.chemphyslip.2014.09.002
   PubMed Web of Science ®Google Scholar
• Parsons, P. E., Eisner, M. D., Thompson, B. T., Matthay, M. A., Ancukiewicz, M., Bernard, G. R., & Wheeler, A. P. (2005). Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Critical Care Medicine, 33(1), 1–6. https://doi.org/10.1097/01.CCM.0000149854.61192.DC
   PubMed Web of Science ®Google Scholar
• Parulekar, A. D., Kao, C. C., DIamant, Z., & Hanania, N. A. (2018). Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: Current knowledge and future needs. Current Opinion in Pulmonary Medicine, 24(1), 50–55. https://doi.org/10.1097/MCP.0000000000000436
   PubMed Web of Science ®Google Scholar
• Passi, M., Shahid, S., Chockalingam, S., Sundar, I. K., & Packirisamy, G. (2020). Conventional and nanotechnology based approaches to combat chronic obstructive pulmonary disease: Implications for chronic airway diseases. International Journal of Nanomedicine, 15, 3803–3826. https://doi.org/10.2147/IJN.S242516
   PubMed Web of Science ®Google Scholar
• Patel, A., Bah, M. A., & Weiner, D. B. (2020). In vivo delivery of nucleic acid-encoded monoclonal antibodies. BioDrugs. https://doi.org/10.1007/s40259-020-00412-3
   Web of Science ®Google Scholar
• Patel, N., Massare, M. J., Tian, J. H., Guebre-Xabier, M., Lu, H., Zhou, H., Maynard, E., Scott, D., Ellingsworth, L., Glenn, G., & Smith, G. (2019). Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection. Vaccine: X, 37(41), 6112–6124. https://doi.org/10.1016/j.vaccine.2019.07.089
   Google Scholar
• Patton, J. S. (2005). Unlocking the opportunity of tight glycaemic control: Innovative delivery of insulin via the lung. Diabetes, Obesity & Metabolism, 7(s1). https://doi.org/10.1111/j.1463-1326.2005.00530.x
   PubMedGoogle Scholar
• Pérez-Gil, J. (2008). Structure of pulmonary surfactant membranes and films: The role of proteins and lipid–protein interactions. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1778(7–8), 1676–1695. https://doi.org/10.1016/j.bbamem.2008.05.003
   PubMed Web of Science ®Google Scholar
• Poh, T. Y., Ali, N. A. T. B. M., MacAogáin, M., Kathawala, M. H., Setyawati, M. I., Ng, K. W., & Chotirmall, S. H. (2018). Inhaled nanomaterials and the respiratory microbiome: Clinical, immunological and toxicological perspectives. Particle and Fibre Toxicology, 15(1). https://doi.org/10.1186/s12989-018-0282-0
   PubMedGoogle Scholar
• Pramanik, S., Mohanto, S., Manne, R., Rajendran, R. R., Deepak, A., Edapully, S. J., Patil, T., & Katari, O. (2021). Nanoparticle-Based drug delivery system: The magic bullet for the treatment of chronic pulmonary diseases. Molecular Pharmaceutics, 18(10), 3671–3718. https://doi.org/10.1021/acs.molpharmaceut.1c00491
   PubMed Web of Science ®Google Scholar
• Pugin, J., Dunn, I., Jolliet, P., Tassaux, D., Magnenat, J. L., Nicod, L. P., & Chevrolet, J. C. (1998). Activation of human macrophages by mechanical ventilation in vitro. American Journal of Physiology-Lung Cellular and Molecular Physiology, 275(6), L1040–L1050. https://doi.org/10.1152/ajplung.1998.275.6.l1040
   PubMed Web of Science ®Google Scholar
• Qiu, K., Durham, P. G., & Anselmo, A. C. (2018). Inorganic nanoparticles and the microbiome. Nano Research, 11(10), 4936–4954. https://doi.org/10.1007/s12274-018-2137-2
   Web of Science ®Google Scholar
• Quadros, M. E., & Marr, L. C. (2010). Environmental and human health risks of aerosolized silver nanoparticles. Journal of the Air & Waste Management Association, 60(7), 770–781. https://doi.org/10.3155/1047-3289.60.7.770
   Web of Science ®Google Scholar
• Raesch, S. S., Tenzer, S., Storck, W., Rurainski, A., Selzer, D., Ruge, C. A., Perez-Gil, J., Schaefer, U. F., & Lehr, C. M. (2015). Proteomic and lipidomic analysis of nanoparticle corona upon contact with lung surfactant reveals differences in protein, but not lipid composition. Agricultural Science & Technology Nano, 9(12), 11872–11885. https://doi.org/10.1021/acsnano.5b04215
   Google Scholar
• Rakaee, M., Busund, L. T. R., Jamaly, S., Paulsen, E. E., Richardsen, E., Andersen, S., Al-Saad, S., Bremnes, R. M., Donnem, T., & Kilvaer, T. K. (2019). Prognostic value of macrophage phenotypes in resectable non–small cell lung cancer assessed by multiplex immunohistochemistry. Neoplasia (United States), 21(3), 282–293. https://doi.org/10.1016/j.neo.2019.01.005
   PubMed Web of Science ®Google Scholar
• Reck, M., Rodríguez-Abreu, D., Robinson, A. G., Hui, R., Csőszi, T., Fülöp, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., O’Brien, M., Rao, S., Hotta, K., Leiby, M. A., Lubiniecki, G. M., Shentu, Y., Rangwala, R., & Brahmer, J. R. (2016). Pembrolizumab versus chemotherapy for PD-L1–positive non–small-cell lung cancer. The New England Journal of Medicine, 375(19), 1823–1833. https://doi.org/10.1056/nejmoa1606774
   PubMed Web of Science ®Google Scholar
• Reda, M., Ngamcherdtrakul, W., Nelson, M. A., Siriwon, N., Wang, R., Zaidan, H. Y., Bejan, D. S., Reda, S., Hoang, N. H., Crumrine, N. A., Rehwaldt, J. P. C., Bindal, A., Mills, G. B., Gray, J. W., & Yantasee, W. (2022). Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment. Nature Communications, 13(1), 4261. https://doi.org/10.1038/s41467-022-31926-9
   PubMed Web of Science ®Google Scholar
• Rengachari, S., Schilbach, S., Aibara, S., Dienemann, C., & Cramer, P. (2021). Structure of the human Mediator–RNA polymerase II pre-initiation complex. Nature, 594(7861), 129–133. https://doi.org/10.1038/s41586-021-03555-7
   PubMed Web of Science ®Google Scholar
• Renukaradhya, G. J., Narasimhan, B., & Mallapragada, S. K. (2015). Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation. Journal of Controlled Release, 219, 622–631. https://doi.org/10.1016/j.jconrel.2015.09.047
   PubMed Web of Science ®Google Scholar
• Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J. P., & Ricciardi-Castagnoli, P. (2001). Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nature Immunology, 2(4), 361–367. https://doi.org/10.1038/86373
   PubMed Web of Science ®Google Scholar
• Rigby, W. F. C., Shen, L., Ball, E. D., Guyre, P. M., & Fanger, M. W. (1984). Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): A morphologic, phenotypic, and functional analysis. Blood, 64(5), 1110–1115. https://doi.org/10.1182/blood.v64.5.1110.bloodjournal6451110
   PubMed Web of Science ®Google Scholar
• Rockett, K. A., Brookes, R., Udalova, I., Vidal, V., Hill, A. V. S., & Kwiatkowski, D. (1998). 1,25-dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of mycobacterium tuberculosis in a human macrophage-like cell line. Infection and Immunity, 66(11), 5314–5321. https://doi.org/10.1128/iai.66.11.5314-5321.1998
   PubMed Web of Science ®Google Scholar
• Rodriguez-Lorenzo, L., Fytianos, K., Blank, F., Von Garnier, C., Rothen-Rutishauser, B., & Petri-Fink, A. (2014). Fluorescence-encoded gold nanoparticles: Library design and modulation of cellular uptake into dendritic cells. Small, 10(7), 1341–1350. https://doi.org/10.1002/smll.201302889
   PubMed Web of Science ®Google Scholar
• Rothman, R. E., Hsieh, Y. H., & Yang, S. (2006). Communicable respiratory threats in the ED: Tuberculosis, influenza, SARS, and other aerosolized infections. Emergency Medicine Clinics of North America, 24(4), 989–1017. https://doi.org/10.1016/j.emc.2006.06.006
   PubMed Web of Science ®Google Scholar
• Sadik, O. A. (2013). Anthropogenic nanoparticles in the environment. Environmental Science: Processes & Impacts, 15(1), 19–20. https://doi.org/10.1039/c2em90063g
   PubMed Web of Science ®Google Scholar
• Safranek, J., Pesta, M., Holubec, L., Kulda, V., Dreslerova, J., Vrzalova, J., Topolcan, O., Pesek, M., Finek, J., & Treska, V. (2009). Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease. Anticancer Research, 29(7), 2513–2517.
   PubMed Web of Science ®Google Scholar
• Salvador-Morales, C., Townsend, P., Flahaut, E., Vénien-Bryan, C., Vlandas, A., Green, M. L. H., & Sim, R. B. (2007). Binding of pulmonary surfactant proteins to carbon nanotubes; potential for damage to lung immune defense mechanisms. Carbon, 45(3), 607–617. N. Y https://doi.org/10.1016/j.carbon.2006.10.011
   Web of Science ®Google Scholar
• Schins, R. (2013). Genotoxicity of nanoparticles. Nanomaterials. https://doi.org/10.1002/9783527673919.ch8
   Google Scholar
• Schleh, C., & Hohlfeld, J. M. (2009). Interaction of nanoparticles with the pulmonary surfactant system. Inhalation Toxicology, 21(sup1), 97–103. https://doi.org/10.1080/08958370903005744
   PubMedGoogle Scholar
• Scott, M. G., Davidson, D. J., Gold, M. R., Bowdish, D., & Hancock, R. E. W. (2002). The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. Journal of Immunology, 169(7), 3883–3891. https://doi.org/10.4049/jimmunol.169.7.3883
   PubMed Web of Science ®Google Scholar
• Segal, L. N., Clemente, J. C., Tsay, J. C. J., Koralov, S. B., Keller, B. C., Wu, B. G., Li, Y., Shen, N., Ghedin, E., Morris, A., Diaz, P., Huang, L., Wikoff, W. R., Ubeda, C., Artacho, A., Rom, W. N., Sterman, D. H., Collman, R. G., Blaser, M. J., & Weiden, M. D. (2016). Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype analysed and interpreted the data HHS public access author manuscript. Nature Microbiology, 1(5). https://doi.org/10.1038/nmicrobiol.2016.31
   PubMed Web of Science ®Google Scholar
• Shao, K., Singha, S., Clemente-Casares, X., Tsai, S., Yang, Y., & Santamaria, P. (2015). Nanoparticle-Based immunotherapy for cancer. Agricultural Science & Technology Nano, 9(1), 16–30. https://doi.org/10.1021/nn5062029
   Google Scholar
• Shapouri-Moghaddam, A., Mohammadian, S., Vazini, H., Taghadosi, M., Esmaeili, S. A., Mardani, F., Seifi, B., Mohammadi, A., Afshari, J. T., & Sahebkar, A. (2018). Macrophage plasticity, polarization, and function in health and disease. Journal of Cellular Physiology, 233(9), 6425–6440. https://doi.org/10.1002/jcp.26429
   PubMed Web of Science ®Google Scholar
• Sharma, A., Vaghasiya, K., Gupta, P., Gupta, U. D., & Verma, R. K. (2018). Reclaiming hijacked phagosomes: Hybrid nano-in-micro encapsulated MIAP peptide ensures host directed therapy by specifically augmenting phagosome-maturation and apoptosis in TB infected macrophage cells. International Journal of Pharmaceutics, 536(1), 50–62. https://doi.org/10.1016/j.ijpharm.2017.11.046
   PubMed Web of Science ®Google Scholar
• Sharma, P., Dhanjal, D. S., Chopra, C., Tambuwala, M. M., Sohal, S. S., van der Spek, P. J., Sharma, H. S., & Satija, S. (2022). Targeting eosinophils in chronic respiratory diseases using nanotechnology-based drug delivery. Chemico-Biological Interactions, 365, 110050. https://doi.org/10.1016/j.cbi.2022.110050
   PubMed Web of Science ®Google Scholar
• Shaw, C. A., Ciarlet, M., Cooper, B. W., Dionigi, L., Keith, P., O’Brien, K. B., Rafie-Kolpin, M., & Dormitzer, P. R. (2013). The path to an RSV vaccine. Current Opinion in Virology, 3(3), 332–342. https://doi.org/10.1016/j.coviro.2013.05.003
   PubMed Web of Science ®Google Scholar
• Sia, J. K., Georgieva, M., & Rengarajan, J. (2015). Innate immune defenses in human tuberculosis: An overview of the interactions between mycobacterium tuberculosis and innate immune cells. Journal of Immunology Research, 2015, 1–12. https://doi.org/10.1155/2015/747543
   Web of Science ®Google Scholar
• Sindrilaru, A., Peters, T., Wieschalka, S., Baican, C., Baican, A., Peter, H., Hainzl, A., Schatz, S., Qi, Y., Schlecht, A., Weiss, J. M., Wlaschek, M., Sunderkötter, C., & Scharffetter-Kochanek, K. (2011). An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. Journal of Clinical Investigation, 121(3), 985–997. https://doi.org/10.1172/JCI44490
   PubMed Web of Science ®Google Scholar
• Smarr, C. B., Yap, W. T., Neef, T. P., Pearson, R. M., Hunter, Z. N., Ifergan, I., Getts, D. R., Bryce, P. J., Shea, L. D., & Miller, S. D. (2016). Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization. Proceedings of the National Academy of Sciences of the United States of America, 113(18), 5059–5064. https://doi.org/10.1073/pnas.1505782113
   PubMed Web of Science ®Google Scholar
• Song, Z., Luo, W., Zheng, H., Zeng, Y., Wang, J., & Chen, T. (2021). Translational nanotherapeutics reprograms immune microenvironment in malignant pleural effusion of lung adenocarcinoma. Advanced Healthcare Materials, 10(12). https://doi.org/10.1002/adhm.202170055
   Web of Science ®Google Scholar
• Sørensen, O. E., Follin, P., Johnsen, A. H., Calafat, J., Sandra Tjabringa, G., Hiemstra, P. S., & Borregaard, N. (2001). Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood, 97(12), 3951–3959. https://doi.org/10.1182/blood.V97.12.3951
   PubMed Web of Science ®Google Scholar
• Soriano, J. B., Kendrick, P. J., Paulson, K. R., Gupta, V., Abrams, E. M., Adedoyin, R. A., Adhikari, T. B., Advani, S. M., Agrawal, A., Ahmadian, E., Alahdab, F., Aljunid, S. M., Altirkawi, K. A., Alvis-Guzman, N., Anber, N. H., Andrei, C. L., Anjomshoa, M., Ansari, F. … Zhang, Y. (2020). Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: A systematic analysis for the global burden of disease study 2017. The Lancet Respiratory Medicine, 8(6), 585–596. https://doi.org/10.1016/S2213-2600(20)30105-3
   PubMed Web of Science ®Google Scholar
• Soroosh, P., Doherty, T. A., Duan, W., Mehta, A. K., Choi, H., Adams, Y. F., Mikulski, Z., Khorram, N., Rosenthal, P., Broide, D. H., & Croft, M. (2013). Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance. Journal of Experimental Medicine, 210(4), 775–788. https://doi.org/10.1084/jem.20121849
   PubMed Web of Science ®Google Scholar
• Spits, H., & Cupedo, T. (2012). Innate lymphoid cells: Emerging insights in development, lineage relationships, and function. Annual Review of Immunology, 30(1), 647–675. https://doi.org/10.1146/annurev-immunol-020711-075053
   PubMedGoogle Scholar
• Stater, E. P., Sonay, A. Y., Hart, C., & Grimm, J. (2021). The ancillary effects of nanoparticles and their implications for nanomedicine. Nature Nanotechnology, 16(11), 1180–1194. https://doi.org/10.1038/s41565-021-01017-9
   PubMed Web of Science ®Google Scholar
• Steen, E. H., Wang, X., Balaji, S., Butte, M. J., Bollyky, P. L., & Keswani, S. G. (2020). The role of the anti-inflammatory cytokine interleukin-10 in tissue fibrosis. Advances in Wound Care, 9(4), 184–198. https://doi.org/10.1089/wound.2019.1032
   Web of Science ®Google Scholar
• Summers, C., Chilvers, E. R., & Michael Peters, A. (2014). Mathematical modeling supports the presence of neutrophil depriming in vivo. Physiological Reports, 2(3), e00241. https://doi.org/10.1002/phy2.241
   PubMedGoogle Scholar
• Summers, C., Singh, N. R., White, J. F., Mackenzie, I. M., Johnston, A., Solanki, C., Balan, K. K., Peters, A. M., & Chilvers, E. R. (2014). Pulmonary retention of primed neutrophils: A novel protective host response, which is impaired in the acute respiratory distress syndrome. Thorax, 69(7), 623–629. https://doi.org/10.1136/thoraxjnl-2013-204742
   PubMed Web of Science ®Google Scholar
• T Hart, B. A., Bogers, W. M., Haanstra, K. G., Verreck, F. A., & Kocken, C. H. (2015). The translational value of non-human primates in preclinical research on infection and immunopathology. European Journal of Pharmacology, 759, 69–83. https://doi.org/10.1016/j.ejphar.2015.03.023
   PubMed Web of Science ®Google Scholar
• Tabeling, C., Scheer, H., Schönrock, S. M., Runge, F., Gutbier, B., Lienau, J., Hamelmann, E., Opitz, B., Suttorp, N., Mayer, K., Behrens, G. M., Tschernig, T., & Witzenrath, M. (2014). Nucleotide oligomerization domain 1 ligation suppressed murine allergen–specific T-cell proliferation and airway hyperresponsiveness. American Journal of Respiratory Cell and Molecular Biology, 50(5), 903–911. https://doi.org/10.1165/rcmb.2013-0333OC
   PubMed Web of Science ®Google Scholar
• Tengroth, L., Millrud, C. R., Kvarnhammar, A. M., Georén, S. K., Latif, L., Cardell, L. O., & Alexopoulou, L. (2014). Functional effects of toll-like receptor (TLR)3, 7, 9, RIG-I and MDA-5 stimulation in nasal epithelial cells. PLoS One, 9(6), e98239. https://doi.org/10.1371/journal.pone.0098239
   PubMed Web of Science ®Google Scholar
• Thompson, E. A. (2014). Innate immune responses to nanoparticle exposure in the lung. Journal of Environmental Immunology and Toxicology, 2(1), 46. https://doi.org/10.7178/jeit.23
   Google Scholar
• Trapnell, B. C., Carey, B. C., Uchida, K., & Suzuki, T. (2009). Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages. Current Opinion in Immunology, 21(5), 514–521. https://doi.org/10.1016/j.coi.2009.09.004
   PubMed Web of Science ®Google Scholar
• Tremblay, L., Valenza, F., Ribeiro, S. P., Li, J., & Slutsky, A. S. (1997). Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. Journal of Clinical Investigation, 99(5), 944–952. https://doi.org/10.1172/JCI119259
   PubMed Web of Science ®Google Scholar
• Tukulula, M., Hayeshi, R., Fonteh, P., Meyer, D., Ndamase, A., Madziva, M. T., Khumalo, V., Lubuschagne, P., Naicker, B., Swai, H., & Dube, A. (2015). Curdlan-conjugated PLGA nanoparticles possess macrophage stimulant activity and drug delivery capabilities. Pharmaceutical Research. https://doi.org/10.1007/s11095-015-1655-9
   Web of Science ®Google Scholar
• Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J. (2014). Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochimica et Biophysica Acta - Molecular Cell Research. https://doi.org/10.1016/j.bbamcr.2014.05.014
   Web of Science ®Google Scholar
• Turvey, S. E., & Broide, D. H. (2010). Innate immunity. The Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2009.07.016
   Web of Science ®Google Scholar
• Unger, S. A., & Bogaert, D. (2017). The respiratory microbiome and respiratory infections. The Journal of Infection, 74, S84–S88. https://doi.org/10.1016/S0163-4453(17)30196-2
   PubMed Web of Science ®Google Scholar
• Van Dalen, F. J., Van Stevendaal, M. H. M. E., Fennemann, F. L., Verdoes, M., & Ilina, O. (2019). Molecular repolarisation of tumour-associated macrophages. Molecules, 24(1), 9. https://doi.org/10.3390/molecules24010009
   Web of Science ®Google Scholar
• Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome. (2000). The New England Journal of Medicine, 342, 1301–1308. https://doi.org/10.1056/nejm200005043421801
   PubMed Web of Science ®Google Scholar
• Verma, R., Lee, C., Jeun, E. J., Yi, J., Kim, K. S., Ghosh, A., Byun, S., Lee, C. G., Kang, H. J., Kim, G. C., Jun, C. D., Jan, G., Suh, C. H., Jung, J. Y., Sprent, J., Rudra, D., De Castro, C., Molinaro, A., Surh, C. D., & Im, S. H. (2018). Cell surface polysaccharides of bifidobacterium bifidum induce the generation of Foxp3+ regulatory T cells. Science Immunology, 3(28). https://doi.org/10.1126/sciimmunol.aat6975
   PubMed Web of Science ®Google Scholar
• Vermaelen, K., & Pauwels, R. (2005). Pulmonary dendritic cells. American Journal of Respiratory and Critical Care Medicine, 172(5), 530–551. https://doi.org/10.1164/rccm.200410-1384SO
   PubMed Web of Science ®Google Scholar
• Vij, N., Min, T., Bodas, M., Gorde, A., & Roy, I. (2016). Neutrophil targeted nano-drug delivery system for chronic obstructive lung diseases. Nanomedicine: Nanotechnology, Biology and Medicine, 12(8), 2415–2427. https://doi.org/10.1016/j.nano.2016.06.008
   PubMed Web of Science ®Google Scholar
• Wallrapp, A., Riesenfeld, S. J., Burkett, P. R., Abdulnour, R. E. E., Nyman, J., Dionne, D., Hofree, M., Cuoco, M. S., Rodman, C., Farouq, D., Haas, B. J., Tickle, T. L., Trombetta, J. J., Baral, P., Klose, C. S. N., Mahlakõiv, T., Artis, D., Rozenblatt-Rosen, O. … Kuchroo, V. K. (2017). The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. Nature, 551(7682), 658–658. https://doi.org/10.1038/nature24029
   PubMed Web of Science ®Google Scholar
• Wang, J., & Fan, Y. (2014). Lung injury induced by TiO2 nanoparticles depends on their structural features: Size, shape, crystal phases, and surface coating. International Journal of Molecular Sciences, 15(12), 22258–22278. https://doi.org/10.3390/ijms151222258
   PubMed Web of Science ®Google Scholar
• Wang, K., Feng, Y., Li, S., Li, W., Chen, X., Yi, R., Zhang, H., & Hong, Z. (2018). Oral delivery of bavachinin-loaded PEG-PLGA nanoparticles for asthma treatment in a murine model. Journal of Biomedical Nanotechnology, 14(10), 1806–1815. https://doi.org/10.1166/jbn.2018.2618
   PubMed Web of Science ®Google Scholar
• Wang, T.-T., Nestel, F. P., Bourdeau, V., Nagai, Y., Wang, Q., Liao, J., Tavera-Mendoza, L., Lin, R., Hanrahan, J. W., Mader, S., & White, J. H. (2004). Cutting edge: 1,25-Dihydroxyvitamin D3 Is a direct inducer of antimicrobial peptide gene expression. Journal of Immunology, 173(10), 6490–6490. https://doi.org/10.4049/jimmunol.173.5.2909
   Web of Science ®Google Scholar
• Weber, G., Heilborn, J. D., Jimenez, C. I. C., Hammarsjö, A., Törmä, H., & Ståhle, M. (2005). Vitamin D induces the antimicrobial protein hCAP18 in human skin [5]. The Journal of Investigative Dermatology, 124(5), 1080–1082. https://doi.org/10.1111/j.0022-202X.2005.23687.x
   PubMed Web of Science ®Google Scholar
• Whitwell, H., Mackay, R. M., Elgy, C., Morgan, C., Griffiths, M., Clark, H., Skipp, P., & Madsen, J. (2016). Nanoparticles in the lung and their protein corona: The few proteins that count. Nanotoxicology, 10(9), 1385–1394. https://doi.org/10.1080/17435390.2016.1218080
   PubMed Web of Science ®Google Scholar
• Woodland, D. L. (2003). Cell-mediated immunity to respiratory virus infections. Current Opinion in Immunology, 15(4), 430–435. https://doi.org/10.1016/S0952-7915(03)00067-0
   PubMed Web of Science ®Google Scholar
• Wu, S., & Sun, J. (2011). Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discovery Medicine, 11(59), 325–335.
   PubMed Web of Science ®Google Scholar
• Wu, T., Zhang, T., Chen, Y., & Tang, M. (2016). Research advances on potential neurotoxicity of quantum dots. Journal of Applied Toxicology: JAT, 36(3), 345–351. https://doi.org/10.1002/jat.3229
   PubMed Web of Science ®Google Scholar
• Xiong, Y., Liu, Y., Cao, L., Wang, D., Guo, M., Jiang, A., Guo, D., Hu, W., Yang, J., Tang, Z., Wu, H., Lin, Y., Zhang, M., Zhang, Q., Shi, M., Liu, Y., Zhou, Y., Lan, K., & Chen, Y. (2020). Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerging Microbes & Infections, 9(1), 761–770. https://doi.org/10.1080/22221751.2020.1747363
   PubMed Web of Science ®Google Scholar
• XU, H., SORURI, A., GIESELER, R. K. H., & PETERS, J. H. (1993). 1,25‐Dihydroxyvitamin D3 exerts opposing effects to IL‐4 on MHC class‐II antigen expression, accessory activity, and phagocytosis of human monocytes. Scandinavian Journal of Immunology, 38(6), 535–540. https://doi.org/10.1111/j.1365-3083.1993.tb03237.x
   PubMed Web of Science ®Google Scholar
• Yagi, K., Huffnagle, G. B., Lukacs, N. W., & Asai, N. (2021). The lung microbiome during health and disease. International Journal of Molecular Sciences, 22(19), 10872. https://doi.org/10.3390/ijms221910872
   PubMed Web of Science ®Google Scholar
• Yang, D., Xing, Y., Song, X., & Qian, Y. (2020). The impact of lung microbiota dysbiosis on inflammation. Immunology, 159(2), 156–166. https://doi.org/10.1111/imm.13139
   PubMed Web of Science ®Google Scholar
• Yang, W., Peters, J. I., & Williams, R. O. (2008). Inhaled nanoparticles—A current review. International Journal of Pharmaceutics, 356(1–2), 239–247. https://doi.org/10.1016/j.ijpharm.2008.02.011
   PubMed Web of Science ®Google Scholar
• Yang, Y., Ding, Y., Fan, B., Wang, Y., Mao, Z., Wang, W., & Wu, J. (2020). Inflammation-targeting polymeric nanoparticles deliver sparfloxacin and tacrolimus for combating acute lung sepsis. Journal of Controlled Release: Official Journal of the Controlled Release Society, 321, 463–474. https://doi.org/10.1016/j.jconrel.2020.02.030
   PubMed Web of Science ®Google Scholar
• Yazdanbakhsh, M., Kremsner, P. G., & Van Ree, R. (2002). Immunology: Allergy, parasites, and the hygiene hypothesis. Science, 296(5567), 490–494. https://doi.org/10.1126/science.296.5567.490
   PubMed Web of Science ®Google Scholar
• Yoshida, T., Yoshioka, Y., Fujimura, M., Yamashita, K., Higashisaka, K., Morishita, Y., Kayamuro, H., Nabeshi, H., Nagano, K., Abe, Y., Kamada, H., Tsunoda, S. I., Itoh, N., Yoshikawa, T., & Tsutsumi, Y. (2011). Promotion of allergic immune responses by intranasally-administrated nanosilica particles in mice. Nanoscale Research Letters, 6(1). https://doi.org/10.1186/1556-276X-6-195
   Google Scholar
• Yu, G., Gail, M. H., Consonni, D., Carugno, M., Humphrys, M., Pesatori, A. C., Caporaso, N. E., Goedert, J. J., Ravel, J., & Landi, M. T. (2016). Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features. Genome Biology, 17(1). https://doi.org/10.1186/s13059-016-1021-1
   Google Scholar
• Yun, Y., Srinivas, G., Kuenzel, S., Linnenbrink, M., Alnahas, S., Bruce, K. D., Steinhoff, U., Baines, J. F., Schaible, U. E., & Di, Y. P. (2014). Environmentally determined differences in the murine lung microbiota and their relation to alveolar architecture. PLoS One, 9(12), e113466. https://doi.org/10.1371/journal.pone.0113466
   PubMed Web of Science ®Google Scholar
• Zhang, H., Christensen, C. L., Dries, R., Oser, M. G., Deng, J., Diskin, B., Li, F., Pan, Y., Zhang, X., Yin, Y., Papadopoulos, E., Pyon, V., Thakurdin, C., Kwiatkowski, N., Jani, K., Rabin, A. R., Castro, D. M., Chen, T. … Wong, K. K. (2020). CDK7 inhibition potentiates genome instability triggering anti-tumor immunity in small cell lung cancer. Cancer Cell, 37(1), 37–54.e9. https://doi.org/10.1016/j.ccell.2019.11.003
   PubMed Web of Science ®Google Scholar
• Zhang, J. M., & An, J. (2007). Cytokines, inflammation, and pain. International Anesthesiology Clinics. https://doi.org/10.1097/AIA.0b013e318034194e
   Google Scholar
• Zhang, Y., Mortimer, M., & Guo, L. H. (2020). Interplay between engineered nanomaterials and microbiota. Environmental Science: Nano, 7(9), 2454–2485. https://doi.org/10.1039/d0en00557f
   Web of Science ®Google Scholar
• Zilker, C., Kozlova, D., Sokolova, V., Yan, H., Epple, M., Überla, K., & Temchura, V. (2017). Nanoparticle-based B-cell targeting vaccines: Tailoring of humoral immune responses by functionalization with different TLR-ligands. Nanomedicine: Nanotechnology, Biology and Medicine, 13(1), 173–182. https://doi.org/10.1016/j.nano.2016.08.028
   PubMed Web of Science ®Google Scholar
• Zlatnik, E. Y., Sitkovskaya, A. O., Nepomnyashchaya, E. M., Dzhandigova, P. R., & Vashchenko, L. N. (2018). Achievements and prospects of cellular technologies based on the activated lymphocytes in the treatment of malignant tumors. Kazan Medical Journal, 99(5), 792–801. https://doi.org/10.17816/kmj2018-792
   Google Scholar
• Zlotnik, A., & Yoshie, O. (2000). Chemokines: A new classification system and their role in immunity. Immunity. https://doi.org/10.1016/S1074-7613(00)80165-X
   Google Scholar